2017
DOI: 10.1016/j.pharmthera.2017.01.001
|View full text |Cite
|
Sign up to set email alerts
|

Adenylyl cyclase signalling complexes – Pharmacological challenges and opportunities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
76
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 87 publications
(78 citation statements)
references
References 111 publications
2
76
0
Order By: Relevance
“…There are 10 different isoforms of ADCYs, and their expression varies among different cell types. Out of these, nine (ADCY1-9) are plasma membrane-bound whereas ADCY10 is soluble and is present in the cytosol (Halls & Cooper, 2017). Interestingly, ADCY1, 3, and 8 are activated by Ca 2+ , while ADCY5 and 6 are inhibited by Ca 2+ (Cooper, 2015;Halls & Cooper, 2017).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…There are 10 different isoforms of ADCYs, and their expression varies among different cell types. Out of these, nine (ADCY1-9) are plasma membrane-bound whereas ADCY10 is soluble and is present in the cytosol (Halls & Cooper, 2017). Interestingly, ADCY1, 3, and 8 are activated by Ca 2+ , while ADCY5 and 6 are inhibited by Ca 2+ (Cooper, 2015;Halls & Cooper, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Out of these, nine (ADCY1-9) are plasma membrane-bound whereas ADCY10 is soluble and is present in the cytosol (Halls & Cooper, 2017). Interestingly, ADCY1, 3, and 8 are activated by Ca 2+ , while ADCY5 and 6 are inhibited by Ca 2+ (Cooper, 2015;Halls & Cooper, 2017). Recently, Orai1 was reported to regulate cAMP generation by physically interacting with ADCY8 resulting in its activation and thereby elevation of cAMP (Willoughby et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…It regulates a variety of cellular functions by regulating the synthesis of cyclic adenosine-3′,5′-monophosphate (cAMP), thereby participating in various pathophysiological processes in the body. 31 Studies have shown that different subtypes of AC have different associations with various diseases, and there is a nonspecific cross-coordination or antagonistic effect between the effect of each subtype effect. 32,33 Nonselective activation/inhibition contributes to many potential adverse reactions.…”
Section: Discussionmentioning
confidence: 99%
“…Using the P-site AC inhibitor 2′-5′-dideoxyadenosine, the authors reported on the intriguing finding that the de novo synthesis of ECM components distinctly depends on cAMP, suggesting that specific cAMP scaffolds are most likely operational in these structural lung cells (Lambers et al, 2014). It will therefore be of interest in the future to study the extent to which distinct ACs (Halls & Cooper, 2017), acting in concert with a distinct subset of PDEs, PKA, and Epac, may contribute to the differential regulation of ECM deposition. Even though such cAMP microdomains have been extensively studied in the cardiovascular system (Laudette et al, 2018;Musheshe, Schmidt, & Zaccolo, 2018), they still have to be defined in more detail in the pulmonary system.…”
Section: Players Of Camp Compartmentalization: Akaps Pka and Epacmentioning
confidence: 99%